Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
EMA considering reactivating transparency policy – The Pink Sheet
The European Medicines Agency will be looking at reviving its policy on proactive publishing of clinical study reports, which is currently suspended as the agency copes with huge staff losses on account of Brexit.
Get the details here.
Transparency rules affecting patentability in Europe? – Nature.com
In this article, the advantages and challenges of increased transparency requirements are discussed, including issues that result in gaining patent protection.
Read the paper here.
Blockchain is key to patient data sharing – Health IT Analytics
Blockchain could potentially improve clinical research by facilitating patient data sharing and improving interoperability, according to a new report by Deloitte.
Read more on the report here.
